{"id":"f-18-fluorocholine","safety":{"commonSideEffects":[{"rate":null,"effect":"Radiation exposure (inherent to PET imaging)"}]},"_chembl":{"chemblId":"CHEMBL5314939","moleculeType":"Small molecule","molecularWeight":"121.17"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"F-18-Fluorocholine is a fluorine-18 labeled choline analog used as a PET tracer. It exploits the increased choline uptake and metabolism in malignant cells compared to normal tissue, allowing detection and localization of tumors. The agent crosses cell membranes via choline transporters and is incorporated into phosphatidylcholine, making it useful for imaging various cancers with elevated choline kinase activity.","oneSentence":"F-18-Fluorocholine is a positron emission tomography (PET) imaging agent that accumulates in cells with high choline metabolism, enabling visualization of metabolically active tissues.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:12:11.327Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"PET imaging of prostate cancer"},{"name":"PET imaging of brain tumors"},{"name":"PET imaging of other malignancies with elevated choline metabolism"}]},"trialDetails":[{"nctId":"NCT03324893","phase":"NA","title":"FCH PET/MRI Parathyroid Localization","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2018-04-03","conditions":"18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary","enrollment":47},{"nctId":"NCT04391348","phase":"NA","title":"Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCC","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-07-17","conditions":"Hepatocellular Carcinoma","enrollment":230},{"nctId":"NCT02640313","phase":"PHASE3","title":"Molecular Imaging of Plaque Vulnerability","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2015-12","conditions":"Plaque, Atherosclerotic","enrollment":14},{"nctId":"NCT04349358","phase":"NA","title":"FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM)","status":"RECRUITING","sponsor":"Centre Georges Francois Leclerc","startDate":"2020-12-15","conditions":"Multiple Myeloma","enrollment":38},{"nctId":"NCT04040946","phase":"PHASE3","title":"Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention","status":"COMPLETED","sponsor":"Centre Francois Baclesse","startDate":"2019-09-19","conditions":"Parathyroid Adenoma, Hyperparathyroidism, F18-choline","enrollment":59},{"nctId":"NCT01310192","phase":"PHASE1","title":"Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography","status":"COMPLETED","sponsor":"Queen's Medical Center","startDate":"2004-06","conditions":"Prostate Cancer","enrollment":20},{"nctId":"NCT00963755","phase":"","title":"F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer","status":"COMPLETED","sponsor":"University of Lausanne Hospitals","startDate":"2009-08","conditions":"Prostate Cancer","enrollment":60},{"nctId":"NCT04102553","phase":"PHASE3","title":"F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence","status":"COMPLETED","sponsor":"ABX advanced biochemical compounds GmbH","startDate":"2019-03-06","conditions":"Prostate Cancer, Prostate Cancer Recurrent","enrollment":200},{"nctId":"NCT02397408","phase":"PHASE2","title":"11C- and 18F-Choline PET/MR Imaging for Prostate Cancer","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2015-04-09","conditions":"Prostate Cancer","enrollment":18},{"nctId":"NCT02121600","phase":"NA","title":"18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2014-09","conditions":"Prostate Cancer","enrollment":5},{"nctId":"NCT02784223","phase":"NA","title":"Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot Study","status":"COMPLETED","sponsor":"Centre Francois Baclesse","startDate":"2016-05","conditions":"Thyroid Gland","enrollment":107},{"nctId":"NCT02432599","phase":"PHASE2","title":"Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas","status":"COMPLETED","sponsor":"Centre Francois Baclesse","startDate":"2015-03","conditions":"Hyperparathyroidism","enrollment":28},{"nctId":"NCT00939315","phase":"","title":"Multimodal Diagnostic Assessment of Cerebral Gliomas With FET & FCH PET/CT, and Magnetic Resonance Imaging/Spectroscopy","status":"COMPLETED","sponsor":"University of Lausanne Hospitals","startDate":"2009-07","conditions":"Glioma","enrollment":51},{"nctId":"NCT02074202","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2014-02","conditions":"Hepatocellular Carcinoma, Liver Disease","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":19,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"F-18-Fluorocholine","genericName":"F-18-Fluorocholine","companyName":"ABX advanced biochemical compounds GmbH","companyId":"abx-advanced-biochemical-compounds-gmbh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"F-18-Fluorocholine is a positron emission tomography (PET) imaging agent that accumulates in cells with high choline metabolism, enabling visualization of metabolically active tissues. Used for PET imaging of prostate cancer, PET imaging of brain tumors, PET imaging of other malignancies with elevated choline metabolism.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}